Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Réponse IgG, IgE et IgG4 anti-allergènes moléculaires : application à la sensibilisation vis-à-vis d’ Aspergillus fumigatus

Autor: Joana Vitte, Ania Carsin, Thomas Romain, Jean-Christophe Dubus, I. Cleach, Martine Reynaud-Gaubert, J.L. Mège, C. Gomez

Publikováno v: Revue Française d'Allergologie. 57:230

Introduction La reponse IgE specifique est un element crucial du faisceau d’arguments diagnostiques d’une allergie, a l’inverse de la reponse IgG correspondante. Aspergillus fumigatus (Af) est un champignon aeroporte ubiquitaire, pathogene oppo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c3d71fe6c23b027246182e404430a3ed
https://doi.org/10.1016/j.reval.2017.02.046

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Asyneuma pichleri (Vis.) D. Lakusic & F. Conti comb. nova (A. sect. Clinocarpium, Campanulaceae), a neglected species from the Balkan Peninsula

Autor: Lakusic, D., Conti, Fabio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3707::67fd69cc03ed0430ef3ebd789737f147
http://hdl.handle.net/11581/304

Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer.

Autor: Zhu X; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, California, USA., Farsh T; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.; Department of Radiation Oncology, UCSF, San Francisco, California, USA., Vis D; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, Netherlands., Yu I; Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada., Li H; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.; Department of Radiation Oncology, UCSF, San Francisco, California, USA., Liu T; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.; Department of Radiation Oncology, UCSF, San Francisco, California, USA., Sjöström M; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.; Department of Radiation Oncology, UCSF, San Francisco, California, USA., Shrestha R; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.; Department of Radiation Oncology, UCSF, San Francisco, California, USA., Kneppers J; Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands., Severson T; Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands., Zhang M; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.; Department of Radiation Oncology, UCSF, San Francisco, California, USA., Lundberg A; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.; Department of Radiation Oncology, UCSF, San Francisco, California, USA., Moreno Rodriguez T; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.; Department of Urology, UCSF, San Francisco, California, USA., Weinstein AS; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.; Department of Radiation Oncology, UCSF, San Francisco, California, USA., Foye A; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, California, USA., Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands., Aggarwal RR; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, California, USA., Bergman AM; Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands., Small EJ; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, California, USA., Lack NA; Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.; Koç University School of Medicine, Istanbul, Turkey.; Koç University Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey., Zwart W; Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands., Quigley DA; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.; Department of Urology, UCSF, San Francisco, California, USA., van der Heijden MS; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, Netherlands., Feng FY; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA.; Department of Radiation Oncology, UCSF, San Francisco, California, USA.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2024 Aug 13; Vol. 134 (19). Date of Electronic Publication: 2024 Aug 13.